Obtaining an accurate diagnosis is a crucial first step in kidney cancer care, according to Dr. Shuanzeng “Sam” Wei of Fox ...

Incyte INCY announced that the FDA has approved the label expansion of Opzelura (ruxolitinib) cream 1.5%. Opzelura, a topical ...

Lenovo today shared updates on the 4th generation of its Genomics Optimization and Scalability Tool - GOAST v4.0. Since its ...

The global transcriptomics market size was US$ 6201.6 million in 2021. The global transcriptomics market size is forecast to reach US$ 11497.7 million by 2030, growing at a compound annual growth rate ...

That’s where Tempus AI (TEM) enters the picture. Going public just last year, Tempus is already experiencing sharp revenue ...

The custom antibody market is set to witness a CAGR of ~10% during the forecast period. The market growth is primarily driven ...

ARK Invest, formally known as ARK Investment Management LLC, is a U.S.-based investment firm founded by Cathie Wood, famous ...

The global prostate cancer diagnostics market is expected to grow at a CAGR of ~12% during the forecast period. Rising ...

He wanted to build a place that redefines humanity’s relationship with nature, a sanctuary where compassion meets science and ...

The company says a single node is capable of processing approximately 22,000 genomes annually, triple the amount of earlier releases.

Alex Zhavoronkov, founder and CEO of Insilico Medicine, explores how A.I. is driving drug discovery breakthroughs—and ...

U.S. chip designer Nvidia has signed a letter of intent for a possible $500 million investment in the next funding round at Britain's Wayve, the autonomous driving technology group said on Thursday ...